Verifying the efficacy of your lead molecules is of crucial importance prior to investing further on lead optimization. Disease models help you to select molecules with therapeutic potential for drug development.
We support you in efficacy screening and proof-of-concept studies with validated disease models and state-of-art techniques. Our comprehensive research approach yields more information from a single study. This allows the elimination of unsuitable compounds and provides valuable input for designing regulatory studies.
All our studies are tailored on customer’s request. We also offer development a novel disease models, including the analytics capabilities in SBW, including genomics, proteomics, non-invasive live-imaging, gross and histopathology, biochemical, clinical chemistry, hematology etc.
Contact us from this link.